Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Perspective

Preserving Brain Function During Development and Aging with Erythropoietin

Author(s): Kenneth Maiese

Volume 16 , Issue 4 , 2019

Page: [289 - 290] Pages: 2

DOI: 10.2174/1567202616999190821143340

[1]
Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293(1): 90-5.
[2]
Maiese K. Regeneration in the nervous system with erythropoietin. Front Biosci (Landmark edition) 2016; 21: 561-96.
[3]
Maiese K. Charting a course for erythropoietin in traumatic brain injury. J Transl Sci 2016; 2(2): 140-4.
[4]
Maiese K. Sirtuins: Developing innovative treatments for aged-related memory loss and Alzheimer’s disease. Curr Neurovasc Res 2018. [Epub ahead of print].
[5]
Sun J, Martin JM, Vanderpoel V, Sumbria RK. The promises and challenges of erythropoietin for treatment of Alzheimer’s disease. Neuromolecular Med 2019. [Epub ahead of print].
[6]
Simon F, Floros N, Ibing W, Schelzig H, Knapsis A. Neurotherapeutic potential of erythropoietin after ischemic injury of the central nervous system. Neural Regenerat Res 2019; 14(8): 1309-12.
[7]
Montesano A, Bonfigli AR, De Luca M, et al. Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes. Sci Reports 2019; 9(1): 10395.
[8]
Xiong T, Yang X, Qu Y, et al. Erythropoietin induces synaptogenesis and neurite repair after hypoxia ischemia-mediated brain injury in neonatal rats. Neuroreport 2019; 30(11): 783-9.

© 2022 Bentham Science Publishers | Privacy Policy